SCHEMBL19806684

SCHEMBL19806684

CC(=O)Nc1[nH]nc(-c2ccc(F)cc2)c1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.59
▸ HDAC6 Q9UBN7 1/20 0.47
▸ LMNA P02545 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ MAPK14 Q16539 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ NR1I2 O75469 1/20 0.43
▸ AHR P35869 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ ADORA2A P29274 1/20 0.43
▸ MAPK1 P28482 3/20 0.42
▸ AXL P30530 1/20 0.42
▸ KEAP1 Q14145 1/20 0.42
▸ MAP2K4 P45985 1/20 0.41
▸ CDK2 P24941 2/20 0.40
▸ CCNA2 P20248 1/20 0.40
▸ CCNA1 P78396 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19806682 0.84 RAB9A (0.58) RAB9AHDAC6LMNAALDH1A1MAPK14
SCHEMBL30572262 0.84 CCNE2 (0.48) RAB9ALMNAALDH1A1MAPK14KDM4E
SCHEMBL25222404 0.74 MAPK1 (0.53) RAB9AMAPK1MEN1KMT2A
SCHEMBL24867506 0.74 MAPK14 (0.50) HDAC6LMNAMAPK14MAPK1
SCHEMBL25258204 0.74 DHODH (0.46) RAB9ALMNAMAPK14KDM4EHPGD
SCHEMBL5317383 0.74 HDAC6 (0.56) RAB9AHDAC6LMNAALDH1A1MAPK14
SCHEMBL14114505 0.73 SMN1; SMN2 (0.41) RAB9AHDAC6LMNAAHRSMN1; SMN2
SCHEMBL25267837 0.73 RAB9A (0.44) RAB9AALDH1A1NPC1SMN1; SMN2MAPK1
SCHEMBL24867343 0.72 PTGDR2 (0.40) HDAC6MAPK14MAPK1POLBDYRK1A
SCHEMBL25210468 0.72 ALDH1A1 (0.47) HDAC6ALDH1A1KDM4ESMN1; SMN2AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018017633-A1 TGF Beta RECEPTOR ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-25 — — WO disclosed
Send feedback